CanDI
CanDI integrates heterogeneous cancer-related datasets by retrieving and indexing public and user-provided data to enable synthesis of multi-source genomic and functional information for hypothesis generation and therapeutic target identification.
Key Features:
- Retrieval and indexing framework: Systematic retrieval and indexing of publicly available datasets to support consolidated querying and analysis.
- User dataset integration: Incorporation of user-specific or bespoke datasets alongside public resources for customized analyses.
- Continuous data updates: Ongoing incorporation of new data to maintain the currency of integrated datasets.
- Hypothesis generation: Integrated analysis facilitates identification of synthetic lethal gene pairs, genes associated with sex disparity in cancer, and potential immunotherapy targets.
Scientific Applications:
- Large-scale cancer data integration: Consolidation of multi-source genomic and functional datasets for comprehensive analysis of cancer biology.
- Discovery of genetic interactions: Identification of synthetic lethal relationships and genes linked to sex disparities in cancer.
- Immunotherapy target identification: Support for discovery of candidate immunotherapy targets through integrated multi-dataset analysis.
- Therapeutic target prioritization: Facilitation of prioritizing candidate targets and generating testable hypotheses for experimental validation.
Methodology:
Systematic retrieval and indexing of data from public sources and integration of user-specific datasets to enable cohesive analysis of data from disparate origins.
Topics
Details
- License:
- MIT
- Cost:
- Free of charge
- Tool Type:
- library
- Operating Systems:
- Mac, Linux, Windows
- Programming Languages:
- Python
- Added:
- 4/2/2022
- Last Updated:
- 4/2/2022
Operations
Data Inputs & Outputs
Data retrieval
Inputs
Outputs
Publications
Yogodzinski C, Arab A, Pritchard JR, Goodarzi H, Gilbert LA. A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy. Genome Medicine. 2021;13(1). doi:10.1186/s13073-021-00987-8. PMID:34663427. PMCID:PMC8524992.
PMID: 34663427
PMCID: PMC8524992
Funding: - National Institutes of Health: DP2 CA239597, K99/R00 CA204602